Intra-Cellular Therapies Market Cap

Macfarlane Group has a market cap or net worth of €181.03 million as of August 1, 2025. Its market cap has decreased by -24.81% in one year.

Market Cap

181.03M

Enterprise Value

232.42M

Revenue

327.02M

Ranking

n/a

PE Ratio

9.64

Stock Price

$1.11

Market Cap Chart

Since February 14, 1992, Macfarlane Group's market cap has increased from 136.34M to 181.03M, an increase of 32.78%. That is a compound annual growth rate of 0.85%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	181.03M	-12.15%
Dec 31, 2024	206.07M	-3.19%
Dec 29, 2023	212.86M	15.44%
Dec 30, 2022	184.39M	-24.51%
Dec 31, 2021	244.26M	58.49%
Dec 31, 2020	154.12M	-23.20%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	284.92B
Siemens Aktiengesellschaft	174.92B
Deutsche Telekom AG	151.49B
Allianz SE	127.59B
Siemens Energy AG	80.60B
Rheinmetall AG	78.24B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	73.00B
Deutsche Bank Aktiengesellschaft	55.70B

Market Cap Rankings